Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

China flag China · Delayed Price · Currency is CNY
30.06
+0.22 (0.74%)
Jun 1, 2026, 3:00 PM CST
Market Cap9.43B -21.5%
Revenue (ttm)1.93B +5.2%
Net Income303.85M -38.1%
EPS0.96 -39.8%
Shares Out 316.05M
PE Ratio31.14
Forward PE14.16
Dividend0.64 (2.15%)
Ex-Dividend Daten/a
Volume1,530,717
Open30.00
Previous Close29.84
Day's Range29.59 - 30.30
52-Week Range28.18 - 50.86
Beta0.36
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:688076

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2,247
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688076
Full Company Profile

Financial Performance

In 2025, SHA:688076's revenue was 1.94 billion, an increase of 19.57% compared to the previous year's 1.62 billion. Earnings were 332.42 million, a decrease of -17.80%.

Financial Statements